Monitor for prospectus supplements indicating actual takedowns under the shelf. Any primary offering will be limited to ~$9.8M per 12 months by the Baby Shelf rule. The Nasdaq compliance deadline (Jan 4, 2027) is the nearer-term catalyst — a reverse split may be needed to regain $1.00 bid price.
Price Chart
Executive Summary
Quanome Technologies filed Amendment No. 3 to its S-3 shelf registration, registering up to $120M in securities (common, preferred, debt, warrants, rights, units). The filing is a routine shelf update for a micro-cap company with a public float of ~$29.3M, subject to a 'Baby Shelf' limitation capping primary offerings at one-third of public float per 12-month period. The company faces Nasdaq minimum bid price non-compliance (deadline Jan 4, 2027), has disposed of its logistics business, and is pivoting to AI compute and quantum-related initiatives with no revenue from new ventures.
Key Financial Metrics
Key Facts
- Shelf registration of up to $120,000,000 in securities (common, preferred, debt, warrants, rights, units).
- Public float of ~$29.3M (34,427,559 non-affiliate shares at $0.85 reference price on Sep 22, 2026).
- Baby Shelf Limitation applies: no more than one-third of public float (~$9.8M) in primary offerings per 12-month period while public float < $75M.
- Stock closed at $0.54 on Sep 30, 2026; Nasdaq bid price non-compliance with cure deadline Jan 4, 2027.
- Substantially all commercial business is PRC-based pharmaceutical distribution via Hupan Pharmaceutical; new AI compute and quantum initiatives have zero revenue.
- Company has provided ~$12.7M in aggregate funding to PRC subsidiaries; no dividends paid or planned.
Financial Impact
Up to $120M shelf registered, but Baby Shelf caps actual primary issuance to ~$9.8M per 12 months given current public float of ~$29.3M.
Risk Factors
- Nasdaq delisting risk if bid price not cured by Jan 4, 2027.
- Dilution from future shelf takedowns, though capped by Baby Shelf limitation.
- PRC regulatory risks (CSRC filing, cybersecurity review, capital controls) for a company with substantially all operations in China.
- New AI compute and quantum initiatives have no revenue and are in early evaluation stage.
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3/A Filing (Primary) | 0001213900-26-105542 |
| Document: ea030681501ex23-1.htm | 0001213900-26-105542 |
| Document: 0001213900-26-105542-index-headers.html | 0001213900-26-105542 |
| Document: 0001213900-26-105542-index.html | 0001213900-26-105542 |
| Document: 0001213900-26-105542.txt | 0001213900-26-105542 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 8-K | $0.4427 $0.4097 | ▲ +7.45% | ▲ +6.93% | $0.4150 (+6.26%) |
Oct 21, 2026 5d ago | 424B5 | $0.4427 $0.4097 | ▲ +7.45% | ▲ +6.93% | $0.4150 (+6.26%) |
Oct 19, 2026 8d ago | EFFECT | $0.5356 $0.4740 | ▲ +11.50% | ▲ +11.84% | $0.4150 (+22.52%) |
Oct 5, 2026 22d ago | 8-K | $0.5790 $0.5220 | ▼ −9.84% | ▼ −10.39% | $0.4150 (−28.32%) |
Oct 1, 2026 25d ago | S-3/A | $0.5382 $0.5600 | ▲ +4.05% | ▲ +3.31% | $0.4150 (−22.89%) |
Oct 1, 2026 25d ago | Press Release | $0.5382 $0.5600 | ▲ +4.05% | ▲ +3.31% | $0.4150 (−22.89%) |
Sep 23, 2026 4w ago | 8-K | $0.8390 $0.8047 | ▼ −4.09% | ▼ −4.01% | $0.4150 (−50.54%) |
Sep 21, 2026 5w ago | 8-K | $0.8509 $0.8390 | ▼ −1.40% | ▼ −0.68% | $0.4150 (−51.23%) |
Sep 2, 2026 7w ago | S-3/A | $0.3280 $0.3241 | ▲ +1.19% | ▲ +2.24% | $0.4150 (−26.52%) |
Aug 20, 2026 9w ago | 8-K | $0.3405 $0.3294 | ▼ −3.26% | ▼ −3.67% | $0.4150 (+21.88%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers